4
Changes in Ownership
Axogen, Inc. Filed Acc 0000805928-21-000184
Chief R&D Officer gave up 286 shares (to pay taxes)
- Chief R&D Officer acquired 1,150 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Scopelianos Angelo Chief R&D Officer | 2021-12-27 | Option exercise | +1,150 | 11,270 | D: show line 1 in the form | ||
| Scopelianos Angelo Chief R&D Officer | 2021-12-27 | Shares withheld for taxes | −286 | $9.74 | $2,786 | 10,984 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Scopelianos Angelo Chief R&D Officer | 2021-12-27 | Option exercise · Restricted Stock Units | −1,150 | 1,150 | D: show line 3 in the form |
Loading xslF345X03/wf-form4_164081344903243.xml…